Zdraveska, Marija
Full Name
Zdraveska, Marija
Vernacular Name
Zdraveska M.
Variants
Zdraveska M
M. Zdraveska
Marija Zdraveska
Lazarevska Marija
Lazarevska M
Здравеска Марија
Здравеска М
Лазаревска Марија
Лазаревска М
Marija Zdravevska
M. Zdraveska
Marija Zdraveska
Lazarevska Marija
Lazarevska M
Здравеска Марија
Здравеска М
Лазаревска Марија
Лазаревска М
Marija Zdravevska
Main Affiliation
![](/image/cris/bar-loader.gif)
![](/image/cris/bar-loader.gif)
Fulltext
Results 1-4 of 4 (Search time: 0.006 seconds).
Preview | Title | Author(s) | Issue Date | Type | |
---|---|---|---|---|---|
1 | The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site. | Mahé I; Chidiac J; Bertoletti L; Font C; Trujillo-Santos J; Peris M; Pérez Ductor C; Nieto S; Grandone E; Monreal M; RIETE investigators; Bosevski M ; Zdraveska M | 2016 | Article | |
2 | Fondaparinux in the initial and long-term treatment of venous thromboembolism | Pesavento R; Amitrano M; Trujillo-Santos J; Di Micco P; Mangiacapra S; López-Jiménez L; Piovella C; Prandoni P; Monreal M; RIETE Investigators.; Bosevski M ; Zdraveska M | 2015 | Article | |
3 | Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis. | Tafur AJ,; Caprini JA,; Cote L; Trujillo-Santos J; Del Toro J,; Garcia-Bragado F; Tolosa C,; Barillari G,; Visona A,; Monreal M; RIETE Investigators; Bosevski, M ; Zdraveska M | 2017 | Article | |
4 | Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens | Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M | 2017 | Article |